Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dong Bok Shin, M.D.,Ph.D.
Gil Medical Center, Gyeonggi, Korea
Principal Investigator - Hye Jin Kang, M.D.,Ph.D.
Korea Cancer Center Hospital , Seoul, Korea
Principal Investigator - Ik-Joo Chung, M.D.,Ph.D.
Chonnam National University Hwasun Hospital, Jeollanamdo, Korea
Principal Investigator - Jee Hyun Kim, M.D.,Ph.D.
Seoul National University Bundang Hospital, Gyeonggi, Korea
Principal Investigator - Joong Bae Ahn, M.D.,Ph.D.
Yonsei Medical Center, Severance Hospital, Seoul, Korea
Principal Investigator - Kyung Hee Lee, M.D.,Ph.D.
Yeungnam University College of Medicine , Daegu, Korea
Principal Investigator - Namsu Lee, M.D.,Ph.D.
Soon Chun Hyang University Hospital , Seoul, Korea
Principal Investigator - Tae Won Kim, M.D.,Ph.D.
Asan Medical Center, Seoul, Korea
Principal Investigator - Tae-Yoo Kim, M.D.,Ph.D.
Seoul National University Hospital , Seoul, Korea
Principal Investigator - Yong Sang Hong, M.D.,Ph.D.
National Cancer Center, Gyeonggi, Korea
Principal Investigator - Young Suk Park, M.D.,Ph.D.
Samsung Medical Center, Seoul, Korea
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Cancer Center
Goyang-si, Gyeonggi-do, South Korea
- Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
- Chonnam National University Hospital
Hwasun, Jeollanamdo, South Korea
- Yeungnam University
Daegu, South Korea
- Gachon University Gil Medical Center
Inchon, South Korea
- Asan Medical Center
Seoul, South Korea
- Korea Cancer Center Hospital
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Soon Chun Hyang University Hospital
Seoul, South Korea
- Yonsei University
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2008
- Primary completion
- 30 Sept 2009
- Completion
- 31 Jan 2011
- Last update posted
- 14 Jun 2013
- Registered enrollment
- 344
- Registry id
- NCT00677443
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.